Latest filing published 20 Apr 2007 for VANTAGEMED CORP, €43k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark Cameron: trading record in brief
Mark Cameron appears in our data through filings on Vantagemed Corp shares, published by SEC (Form 4). The record holds 9 filings, for trades running from 14 June 2006 to 18 April 2007.
On the market, this insider has only ever bought: 1 purchase, €3,959 in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 5 option exercises.
On 23 April 2007 came the latest disclosure, an option exercise for €4,489 in Vantagemed Corp. The clock since the last published purchase (31 July 2006) now reads 7,406 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark Cameron
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 77,583 shares@ US$0.75vantagemed common stockSEC:0001179110-07-008133:0
- 39,581 shares@ US$0.67vantagemed common stockSEC:0001179110-07-008133:1
- 11,120 shares@ US$0.55vantagemed common stockSEC:0001179110-07-008139:1
- 88,703 shares@ US$0.75vantagemed common stockSEC:0001179110-07-008139:2
- 11,120 shares@ US$0.45common stockSEC:0001179110-06-015777:0Canonical exit: 12 Sept 2006 (T+90)
5 of 5 declarations